Brainstorm Cell Therapeutics Inc. (BCLI)
Free Cash Flow Growth
74.44%
Quarterly · Period ending:
BCLI Free Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported74.44%period ending
Latest reported74.44%period ending
BCLI Quarterly Free Cash Flow YoY % (76.83% → 74.44%)
Year-over-year change
High-resolution chart · PNG
BCLI free cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Free Cash Flow Growth |
|---|---|
| 74.4432% | |
| 19.0681% | |
| 29.3893% | |
| 66.5959% | |
| -108.0808% | |
| 46.7516% | |
| 68.0974% | |
| 48.6697% | |
| 75.1697% | |
| 23.156% | |
| 29.3244% | |
| -32.4881% | |
| -10.1576% | |
| -7.8171% | |
| 16.1465% | |
| 27.5646% | |
| -14.8591% | |
| 58.9131% | |
| 29.036% | |
| 4.4923% | |
| 6.215% | |
| 40.157% | |
| -115.5353% | |
| -88.0901% | |
| -61.8589% | |
| -1,692.1335% | |
| 5.4033% | |
| 43.4723% | |
| -2,105.625% | |
| 61.3542% | |
| -27.8278% | |
| -275.539% | |
| 90.373% | |
| -32.2168% | |
| -149.1272% | |
| 1,413.6364% | |
| -13.4471% | |
| 45.3941% | |
| 8.0275% | |
| 88.749% | |
| 12.0648% | |
| -55.2401% | |
| 36.9335% | |
| -127.1671% | |
| -71.7526% | |
| -299.3814% | |
| -28.1038% | |
| -50.4032% | |
| 12.5338% | |
| 29.7101% | |
| -133.9595% | |
| 31.6176% | |
| -159.1121% | |
| 13.5338% | |
| -43.8669% | |
| -21.1581% | |
| 46.5% | |
| -767.3913% | |
| 12.5455% | |
| -123.9401% | |
| -53.5509% | |
| 84.7176% | |
| -18.2796% | |
| -88.2629% | |
| -798.2759% | |
| -271.6049% | |
| -37.574% | |
| 52.349% | |
| 87.7378% | |
| 80.3159% | |
| 30.5955% | |
| 57.1429% | |
| -54.7836% | |
| -188.3551% | |
| -79.3653% | |
| -220.6163% | |
| 31.9221% | |
| 31.4283% | |
| 21.3307% | |
| 0.9644% | |
| -20.6365% | |
| -110.5885% | |
| 28.7336% | |
| -1,994.3426% | |
| -3,936.8014% | |
| -2,735.6958% | |
| -9,705.3047% | |
| 648.9079% | |
| 2,735.3261% | |
| -466.6667% | |
| -1,578.7425% | |
| 30.2341% | |
| 76.8262% |